 |
|
     |
|
 |
July 22,
2003 A recent Washington conference on “conflicted science” reminds us that the health research enterprise is a public-private affair, causing some to fear that formerly independent clinical researchers are turning into well-compensated industry cheerleaders. But if a researcher wants to forgo corporate money, where will he or she get the funding to continue a study? Applied clinical research already receives scant federal funding, making it increasingly likely that the corporate world will pay for the trials that could improve people’s health. As our story below suggests, there are hidden costs to this arrangement. HABIT is going on vacation in August, but we hope you’ll join us again in the fall after taking some time off to recharge your batteries as well. Cheers --
|
|
|||||
 |
|||||||
